Meltem Ekenel

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Outcomes of [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide in metastatic castration-resistant prostate cancer: a single-center retrospective study.

Outcomes of [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide in metastatic castration-resistant prostate cancer: a single-center retrospective study.

Journal: European journal of nuclear medicine and molecular imaging
Published: July 02, 2026

Prognostic Impact of Metastatic Pattern in Renal Cell Carcinoma: IMDC, IMDC-7, and Meet-URO Scores.

Prognostic Impact of Metastatic Pattern in Renal Cell Carcinoma: IMDC, IMDC-7, and Meet-URO Scores.

Journal: Journal of kidney cancer and VHL
Published: January 17, 2026

Comparison of second-line treatments in metastatic renal cell carcinoma patients: A single-center experience.

Comparison of second-line treatments in metastatic renal cell carcinoma patients: A single-center experience.

Journal: Medicine
Published: October 13, 2023

The use of bevacizumab in primary malignant tumors of the central nervous system: A single-center experience.

The use of bevacizumab in primary malignant tumors of the central nervous system: A single-center experience.

Journal: Medicine
Published: July 28, 2023

Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort.

Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort.

Journal: Journal of chemotherapy (Florence, Italy)
Published: May 22, 2023

Clinical course and features of soft tissue sarcomas in geriatric patients: a single-center experience.

Clinical course and features of soft tissue sarcomas in geriatric patients: a single-center experience.

Journal: The Journal of international medical research
Published: March 07, 2023

A rare case of ruptured liver metastases from a laryngeal cancer.

A rare case of ruptured liver metastases from a laryngeal cancer.

Journal: Radiology case reports
Published: July 04, 2021

Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.

Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: June 17, 2021

Safety of Fibroblast Activation Protein-Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04.

Safety of Fibroblast Activation Protein-Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04.

Journal: Clinical nuclear medicine
Published: April 22, 2021

177Lu-PSMA Therapy for Metastatic Testicular Mixed Germ Cell Tumor.

177Lu-PSMA Therapy for Metastatic Testicular Mixed Germ Cell Tumor.

Journal: Clinical nuclear medicine
Published: February 25, 2021

Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.

Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.

Journal: International journal of clinical oncology
Published: February 22, 2021

Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?

Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?

Journal: Annals of nuclear medicine
Published: December 09, 2020
Showing 1-12 of 33

Last Updated: 09/26/2026